Skip to content

Access

Semaglutide salt forms

Versions of semaglutide such as semaglutide sodium and semaglutide acetate, which the FDA says are different active ingredients from the semaglutide base used in approved drugs, with no known lawful basis for compounding.

By the glp1.how editorial teamReviewed

The FDA-approved semaglutide products (Ozempic, Wegovy, and Rybelsus) contain semaglutide in its base form. Some compounded semaglutide has instead been made from salt forms, most often semaglutide sodium or semaglutide acetate, where the drug molecule is paired with a different counter-ion. A salt form is chemically a different active ingredient, and it hasn't been through the testing the base form went through.

Since 2023 the FDA has warned (external link) that it has no information showing these salts have the same chemical and pharmacologic properties as the approved ingredient, and that it knows of no lawful basis for compounding with them. State pharmacy boards issued similar warnings. If you use a compounded product, ask the pharmacy which form of semaglutide it uses and where the ingredient comes from. See how compounded GLP-1 medications are made and pharmacy sources for GLP-1 medications.

semaglutidecompoundingsafetyfdaaccessglossary

Revision history

Updated 2 times since Sep 26, 2026 · show changes
  1. v3

    Body revised

  2. v2

    Published

  3. v1

    First version

Related guides

  • How compounded GLP-1 medications are made — and how that differs from the branded pens · A compounded GLP-1 is mixed from raw active ingredient at a pharmacy; it does not come off a branded production line. This guide explains how the drug substance is sourced, how the formula and dose are set, how a sterile compounding pharmacy makes the vial, and how that compares with the tightly controlled, FDA-approved process behind Ozempic, Wegovy, and Zepbound.
  • "Research peptides" and GLP-1 medications: what they are, and what the label doesn't tell you · "Research peptides" are GLP-1 drugs such as semaglutide, tirzepatide, and retatrutide, sold as powder in vials stamped "research use only, not for human consumption." That label is a legal workaround and says nothing about safety. This guide covers where these products come from, what independent testing found inside the vials, why the "research" disclaimer does not make them regulated or safe, and the documented harms behind a rise in poison-control calls.
  • How to verify a pharmacy is legitimate: BeSafeRx, NABP, and your state board · Our sourcing guides keep ending on the same instruction (verify the pharmacy with your state board, the NABP, or FDA's BeSafeRx) without saying how. This is the step-by-step: the free tools each one offers, what red flags to look for, how to pull a pharmacy's license record, and how to check your own pen's lot number against FDA's counterfeit alerts. About five minutes, start to finish.
  • Applying for a GLP-1 patient assistance program: step by step · Novo Nordisk's PAP and Lilly Cares can provide Ozempic or Trulicity free to people who qualify by income and insurance status, but as of September 2026 neither covers Wegovy, Zepbound, Saxenda, or Foundayo. Here's who qualifies, the 2026 income limits in dollars, the documents you need, your prescriber's role, turnaround and renewal, what to do if you're denied, and how PAPs differ from savings cards and direct-pay.
  • LillyDirect vs. NovoCare: how manufacturer direct-pay actually works · Both GLP-1 makers now sell their brand medications straight to cash-paying patients: Lilly through LillyDirect, Novo Nordisk through NovoCare Pharmacy. This guide explains how these direct-pay channels work, how single-dose vials differ from pens, how a flat cash price differs from a savings card, and the problems direct-pay doesn't solve.
  • Pharmacy sources for GLP-1 medications: compounded, telehealth, and counterfeit risks · The brand shortages that made compounded GLP-1s widely available ended in late 2024 and early 2025, and where people get these drugs has shifted since. Counterfeit Ozempic has turned up in the legitimate supply chain three times. This guide shows how to tell the fully legitimate routes from compounded grey areas and outright dangerous sellers, and how to vet any source before you inject.

Related terms

  • Semaglutide · A GLP-1 receptor agonist medication made by Novo Nordisk, sold under the brand names Ozempic (type 2 diabetes) and Wegovy (weight management), each as an injection or a pill.
  • Ozempic · Novo Nordisk's brand name for semaglutide for type 2 diabetes, sold as a weekly injection and, since May 2026 in the US, as daily Ozempic tablets.
  • Wegovy · Novo Nordisk's brand name for semaglutide (weekly injection or, since December 2025, a daily pill), FDA-approved for chronic weight management and heart-risk reduction, and as an injection for MASH liver disease.
  • Compounded semaglutide · A version of semaglutide made by a compounding pharmacy rather than the original manufacturer — not FDA-approved as a standalone product.

Was this helpful?

Improve this page